Catalyst
Slingshot members are tracking this event:
After positive Alkermes FORWARD-5 study on ALKS-5461 in treating Major Depressive Disorder (MDD), company plans to submit a New Drug Application in the second half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALKS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 21, 2017
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=92211&p=irol-corporateNewsArticle&ID=2294753
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Alks 5461, Forward-5, Phase 3 Study, Major Depressive Disorder
